ABSTRACT
INTRODUCTION
The need to represent a patient's family history information associated with clinical and genomic data was introduced as a storyboard to the Clinical Genomics Special Interest Group (SIG) in HL7 (CG, 2005) . The SIG develops HL7 standards (HL7, 2005) to enable the exchange of interrelated clinical and personalized genomic data between disparate organizations (e.g., health care providers, genetic labs, research facilities, pharmaceutical companies). Agreed-upon standards to allow this exchange are crucial, as it is envisioned that the use of genomic data in health care practice will become ubiquitous in the near future. A few emerging cases for this include tissue typing, genetic testing (e.g., cystic fibrosis, BRCA1, BRCA2), and pharmacogenomics clinical trials. These cases are represented in the SIG storyboards, which have led to the development of the Genotype model as the basic unit of genomic data representation, focusing on a specific chromosomal locus.
It was determined that there was a set of basic information required to record a family history and to create a pedigree for the purpose of breast cancer risk assessment (Thull & Vogel, 2004) . For each family member, this set included the information about his or her relationships to other members of the family and the information regarding his or her health. Relationship information included the type of relative, a personal identifier, and the identifier of the person's mother and father. Health information data included disease type, age at diagnosis, current age or age of death, genetic syndrome suspected, genetic test done, genetic test result as raw data, and interpretation of genetic test.
The explosion in our knowledge of genetics has increased our understanding of the hereditary basis of many diseases. While we present here the example of exchanging family history and risk information relative to breast cancer, we believe this model can be used for the exchange of any hereditary risk information.
An outline of the patient's family history is presented in Appendix A. Populating this data set with patient data results is the example shown in Table 1 .
Storyboard Presentation
The following fictitious scenario demonstrates the potential use of the semantic Web (Berners-Lee, Hendler & Lassila, 2001) in offering services of exchanging family history information. Note that this is an abridged version of the full presentation contained in the HL7 specifications (CG, 2005) . els), where the patient's family history already has been received. The counselor edits the data after confirming and clarifying various issues with the patient and adds additional information that was not entered at home. 5. The patient is considered to be at high risk, and she is told that she is a candidate for genetic testing. This includes a thorough discussion of the pros and cons of testing. The patient decides not to have testing and leaves. 6. The counselor at the risk clinic sends back the updated family history to the Surgeon General History tool, so that the patient can use it in future encounters, if needed.
In this fictitious scenario, both the Surgeon General and CAGENE programs use publicly available Web Services that transform the data to the format needed by the receiving application, if it is not yet complying with the HL7 specs. The various aspects by which this kind of storyboard relates to the current processes are described in Table 2 , where the left column shows the current practice, and the right column shows the proposed improvements. The scenario described in Table 2 is more complex than the previous, as it includes the use of three more family history programs with their own data formats as well as results from a genetic testing facility.
THE FAMILY HISTORY EXCHANGE MODEL
Following the previous analysis of a patient's family history outline as well as Martha Francis is a 39-year-old woman with ovarian cancer. She has a family history of breast and ovarian cancer and believes she may be carrying a BRCA1 or BRCA2 mutation (which predisposes to breast and ovarian cancer).
She downloads the Surgeon General's Family History tool onto her computer at home and enters her family history.
She uses the Surgeon General's Family History Web-based tool from her home and enters her family history.
She then prints out her information onto paper and brings the paper to her clinician.
She then sends the data to her clinician (the Surgeon General's tool uses Web Services to export its data to the HL7 format and then to transform it to the clinician's system format). Her clinician types the information from the paper into the homegrown electronic medical record (EHR).
Her clinician is able to see her family history as part of the homegrown electronic health record (EHR) system used in the clinician's office.
The clinician reviews the family history with the patient and makes corrections and additions in the EHR.
The clinician reviews the family history with the patient and makes corrections and additions in family history information of the patient's EHR.
The patient is considered to be at high risk of having a mutation, and this information is given to her.
She is referred to a risk clinic.
Francis' family history details are printed on paper and sent to the risk clinic.
Francis' family history details are sent to the risk clinic (the clinician's system uses Web Services to export its data to the HL7 format and then to transform it to the risk clinic's required format). The counselor at the risk clinic (nurse geneticist, nurse practitioner, genetic counselor, doctor, etc.) types the data into a number of programs: (1) Progeny (Progeny, 2005) to draw a pedigree; (2) CAGENE (CaGene, 2005) to run risk models; and (3) a homegrown Microsoft Access database to hold various and sundry other data. The counselor then reviews the family history information collected by the primary clinician, edits it, reviews results of the risk model algorithms, decides what genetic syndrome her family might have, and categorizes the patient as to degree of risk.
The counselor at the risk clinic (nurse geneticist, nurse practitioner, genetic counselor, doctor, etc.) imports the patient's family history information into a number of programs: (1) Progeny (Progeny, 2005) to draw a pedigree; (2) CAGENE (CaGene, 2005) to run risk models; and (3) a homegrown Microsoft Access database to hold various and sundry other data. The counselor then reviews the family history information collected by the primary clinician, edits it, reviews results of the risk model algorithms, decides what genetic syndrome her family might have, and categorizes the patient as to degree of risk. The counselor speaks with the patient and adds additional information to the databases.
The counselor speaks with the patient and adds additional information to the databases.
The patient is considered to be at high risk, and she is told she is a candidate for genetic testing. This includes a thorough discussion of the pros and cons of testing.
The order for testing is issued, and the family history information is included with the lab requisition (required by the testing laboratory). The family history information is transcribed by hand onto a paper lab requisition, which is sent to the testing facility along with a blood sample.
The order for testing is issued, and the family history information is included with the lab requisition (required by the testing laboratory). Data are sent to the testing facility through the aforementioned family history Web Services, along with a delivery of a blood sample.
At the central testing facility, the family history data are typed into the database (homegrown).
At the central testing facility, the HL7 message received from the family history Web Services is imported into the database (homegrown). Testing of the BRCA1 and BRCA 2 genes for mutations is undertaken.
Testing of the BRCA1 and BRCA 2 genes for mutations is undertaken.
The results are entered into the database.
The results are entered into the database. Identified mutations are assessed for functional significance by determining if they are truncating (deleterious), or if they are irrelevant (no change in amino acid coded by that codon). All other mutations are compared to known mutations to determine if information is available on their functional significance. In this case, a mutation is identified in BRCA1 and the mutation is deleterious.
Identified mutations are assessed for functional significance by determining if they are truncating (deleterious) or if they are irrelevant (no change in amino acid coded by that codon). All other mutations are compared to known mutations to determine if information is available on their functional significance. In this case, a mutation is identified in BRCA1 and the mutation is deleterious.
The actual mutations and the assessment of functional significance are printed on paper, which is sent to the counselor.
The actual mutations and possibly the entire gene sequences as well as the assessment of functional significance are exported using the HL7 Genotype model, which is part of the family history standard specification. The Genotype model is known to clinical genomics Web Services that annotate the genomic data by the most updated knowledge and to associate it with the patient clinical history. The annotated results are sent to the counselor. The counselor types the results into his or her databases, makes comments, and then prints a final report, which is sent to the primary provider and to the patient.
The counselor receives the results through his or her family history program and further annotates it. The counselor then sends the information to the primary provider and to the patient so both can update their records. As in all information exchanges thus far, this is seamlessly accomplished through publicly available Web Services that can transform all known family history formats through HL7 standards specifications. Holds the estimated age of the subject when the observation was made. The code attribute is fixed to LOINC code ("21611-9" )that represents the concept of an estimated age as opposed to a precise age.. This model is intended to be a CMET and has the capability of representing any part of the pat ient pedigree.
Note:
Estimated age (current or deceased) of the patient / relative when his/her birth date is unknown. The code is fixed to LOINC code "21611-9" that represents the concept of an estimated age vs. precise age. 
Shadow of the estimated age choice for current or deceased age.
This association should hang of f the choice box so that an estimated age could be attributed to the Gentotype CMET. However, the current HL7 methodology doesn't support exiting from a CMET. sents a pedigree. We then were able to generate automatically an XML schema from these models and to experiment with family history information exchange. Figure 1 shows a bird's eye view of the Family History model utilizing the Genotype model to represent optional genomic data for the patient and each of his or her relatives.
Genotype Model

UNDERLYING STANDARDS AND TECHNOLOGIES
The following sections describe standards and technologies that underlie the family history model and enable its potential use in the semantic Web.
HL7 Standards as a Foundation for Semantic Interoperability
The HL7 standard specifications focus on the seventh layer of the ISO Open Systems Interconnection model (i.e., the the contextual storyboard presentation, we have developed an HL7 model to allow the representation of a pedigree with an unlimited depth of generations. The model addresses the storyboard requirements while making use of the Genotype model for embedding genomic data at any level of granularity available and needed.
The modeling effort is based on the new HL7 Reference Information Model (RIM) from which all HL7 V3 specs are derived (e.g., labs, pharmacy, clinical documents, clinical trials, etc.). The HL7 RIM (RIM, 2005) has four core classes that basically allow the representation of an entity playing a role that has a participation in an act. For example, a person is playing a role of a relative that has a participation in an observation act of clinical and genomic data. By using the dedicated HL7 tools, we created UML-like models, where we refined the core RIM classes and associated them in a way that repre-semantic level that defines the contents of the messages exchanged between disparate systems within and across enterprises). An outstanding example of such use of HL7 is the principle design of the UK NHS NPfIT (National Health ServiceNational Program for IT) (Williams et al., 2004) . It is a radical approach to change the entire strategy for information service provision in England and Wales. The plan is to have a foundation layer of nationwide applications running over a new broadband infrastructure and exchanging information using HL7 version 3 messages extended and localized by the requirements of this program. Three main applications are built on these new infrastructures: (1) a national e-booking system that enables the patient to participate in where and when an appointment is made; (2) an electronic transmission of prescriptions that will enable prescriptions to be sent electronically between GPs and retail pharmacies; and (3) a national integrated patient care service. The national patient record system, comprising a medical snapshot of every patient, will be fed into a national spine on top of the IT infrastructure. The spine will link the full range of the IT services specified locally. As a result, electronic patient records will be held centrally and will be available from all parts of the NHS with improved debugging, duplication, and management facilities, compared to today's dispersed and fragmented systems. The UK multi-billiondollar NPfIT implementation (started in 2004) is a quantum leap compared to the current health care situation in the UK, and it is all built around HL7 standard specifications -a crucial enabler of semantic interoperability on a large national scale. A similar initiative for National Health Information Infrastructure now is evolving in the US, although with different architecture -less centralized than the UK (ONCHIT, 2005) . As in the UK, it also is built around health care standards as main enablers of semantic interoperability. More national health IT initiatives are going on these days around the globe, some of which are based on HL7 standards; for example, in Finland (Porrasmaa, 2004) , the Netherlands (NICTIZ, 2005), Canada (InfoWay, 2005) , and Australia (HealthConnect, 2005) .
Development Methodologies and Technologies
The development of HL7 specifications follows the HL7 Development Framework (HDF, 2005), a methodology that dictates the use of pure UML models to represent the domain analysis and activity in the storyboards of interest to each working group (e.g., laboratory, pharmacy, medical records, clinical genomics). After the completion of these domain-specific UML models to the satisfaction of the domain experts, the working group represents these models through the HL7 RIM building blocks, resulting in an HL7 Domain Information Model (a UML-like model with HL7-specific constraints). The latter then serves as a basis of creating several HL7 Message Information Models that can be serialized to Hierarchical Message Descriptions and organized into interaction sets. The aforementioned artifacts are being balloted and sent to ANSI. For implementation purposes, the HL7 specifications could be translated to some implementable technology like XML. The resulting XML schemas are not considered part of the balloted content but rather one option of implementation, taking into account that at a later time, there might be new implementation technologies for the same standard specifications. Note that only HL7 Message Information Models can be translated to XML schemas, as they are serializable models as opposed to Domain Information Models that can be more complex, encompassing all relevant data and associations in the domain.
The process of creating HL7 specifications is facilitated by a suite of tools developed specifically for HL7; a drawing tool allows the designer to draw an HL7 model from a pallet of RIM core classes. It also allows the validation of the model and its storage in a design repository. Another tool serializes a Message Information Model into a Hierarchical Message Description (HMD) exported into an XML format. Finally, a schema generator, which is part of the HL7 XML ITS (Implementable Technology Specification), generates an XML schema out of the HMD representation.
The Genotype Model As aforementioned, the Family History model utilizes the HL7 Genotype model to carry genomic data relevant to the patient's family history. The Genotype model is intended to be used as a shared component in any HL7 specification that conveys genomic data. It embeds various types of genomic data relating to a chromosomal locus, including sequence variations, gene expression, and proteomics. Within the Genotype model, we have utilized existing bioinformatics markups that commonly are used by the genomic community (e.g., MAGE-ML for gene expression data or BSML for DNA sequences). Those bioinformatics markups represent the raw genomic data and are encapsulated in HL7 objects. On the other hand, only portions of the raw and mass genomic data are relevant to clinical practice. To that end, we have constrained the full-blown bioinformatics markup schemas and excluded areas that describe pure research data. More importantly, the Genotype model also includes specialized HL7 objects (e.g., SequenceVariation of SNP type) that hold those portions of the raw genomic data that seem to be significant to clinical practice. Those specialized objects have attributes that represent the essential genomic data along with optional annotation. They are populated through a bubbling-up process that dedicated applications carry out. The bubbling-up process should take into account the goals of clinical care, the patient-specific history, and the most current knowledge about relevant clinical-genomic correlations. Once populated, those specialized objects can be associated with Clinical Phenotypes, represented either internally within the Genotype model or elsewhere; for example, as diagnoses and allergies residing in the patient medical records. Figure 2 shows a bird's eye view of the Genotype model, distinguishing between the encapsulating objects vs. bubble-up objects. Figure 3 illustrates a possible use of the encapsulate and bubble-up paradigm in the case of family history data. The genetic testing lab sends raw genomic data encapsulated in the Genotype encapsulating objects (e.g., full sequencing of the BRCA1 gene, expressed with BSML and encapsulated in the Sequence object of the Genotype model). When this portion of the HL7 message arrives at the EHR system, it gets appended to the patient's family history. We then envision that specialized decision support services will parse the family history and bubble up those SNPs in the raw data that are most clinically significant to the goal of assessing patient risk, resulting in annotation and enrichment of the data to be more useful to clinical practice. Thus, we envision that services will not only enable the exchange of information from one proprietary format to the other but also leverage it to be more effective to the receiving user.
Note that several bubbling-up processes could be performed at the same time (e.g., different algorithms, ontologies, etc.) and in different times (e.g., when new discoveries become available and the same raw data can be interpreted differently). Therefore, it is important not to abstract away the raw genomic data of a specific patient but rather encapsulate it and make it available to any processes that attempt to associate it with clinical data and facilitate a clinical decision at the point of care.
The Clinical Statement Model
The clinical data in the family history model might be represented using a shared model of a clinical statement, which is under development in HL7 by various working groups (e.g., the Structured Documents Committee, the Orders and Observations Committee, the Patient Care Committee). The clinical statement model provides the grammar of how various discrete acts (observations, procedures, substance administrations, etc.) are associated to generate a meaningful clinical statement.
The EHR Functional Model
The HL7 EHR Functional Model (recently approved as a DSTU -Draft Standard for Trial Use) has a family history function stating the information found in Table 3 .
It is expected that this draft standard will be mandatory in the near future and that every EHR system will comply with certain profiles derived from this standard. The US government is developing an incentives program (through the CMS, for example) to encourage providers to adopt EHR systems that comply with this standard (conformance metrics are being developed) as well as to encourage EHR vendors to offer their systems in accordance with the standards functions (Dickinson, Fischetti & Heard, 2003) .
The HL7 Health Care Services
Standardization Effort Further to the aforementioned EHR Functional Model, there is a new effort to define standard services for EHR systems, undertaken jointly by HL7 and OMG. This will lead to the realization of a semantic Web for health care, as functions defined The C linicalPhenotype objects should be replac ed with the HL7 C linical Statement model when it's ready for use. Also, sinc e the HL7 tooling doesn't enable the shadow ing of a choic e box, all other objects in the Genotype model are as soc iated with merely C linicalPhenotype instead of the entire "Clinic alPhenotype" c hoice box. Consequently, t he KnownAssoc iatedD isease objec t is accessible only from the Sequence Variation object and its common main use cas e is annotating a mutation.
Note:
The The term 'Genotype' refers to ALL genomic aspects of a specific c hromosomal locus.
The term 'Individual Allele' doesn't refer necessarily to a known variant of the gene, rather it refers to the personalized data regarding the gene that might well contain personal variations w/unknown significance. in the functional model will be available as Web Services, either by the enterprise EHR system or by trusted third parties, who will provide Web Services for interoperability of EHR systems as well as for decision support and annotation. In order to move forward in this direction, it is necessary for health care enterprises to implement a service-oriented architecture while establishing service offerings within such architecture. Realization of service-oriented health care interoperability is based on identifying the business functions and behavior being performed by a set of agreed-upon services as well as defining conformance metrics. This work is predicated on the availability of a robust semantic model describing precisely the information payload across organizations (Rubin, 2005) .
GeneAssociatedObservation
OWL and the HL7 Templates
The specifications developed thus far in HL7 are general-purpose specs and are not customized or constrained to specific requirements from the various clinical domains and their subspecialties. For example, there is a generic specification of a clinical document, but there is not a standard way of representing a discharge summary. The HL7 Templates SIG's mission is to address this issue of specialization and customization by offering mechanisms for constraining the generic specifications (Elkin & Kernberg, 2005) . Template specifications eventually will constitute the majority of the HL7 standards, including specialized domains such as clinical genomics. One candidate formalism for expressing templates is OWL (Heflin, 2004) , and once approved as a standard template mechanism (currently under ballot), the HL7 Clinical Genomics SIG will attempt to represent its specifications using OWL. Using OWL representations will allow designers to better constrain the generic specifications and to elaborate them in order to create a rich set of specialized data constructs in their clinical domain. The current HL7 methodology and tooling do not permit the structured representation of constraints over generic HL7 models. The current practice is to use a constraint box pointing to a class or attribute in the model and to specify the constraint in free text. This is a limited mechanism that will be improved once these balloted models can be constrained further using languages such as OWL. In addition, OWL representations will make the HL7 specs a better fit for the semantic Web. 
IMPLEMENTATION
We have implemented the Family History model by automatically generating the XML schema from the model and crafting XML samples with actual patients' family history data that validate that schema. We also added patient-specific BRCA sequences to illustrate the benefits of encapsulating raw genomic data in the context of BRCA risk assessment. We are now working with various stakeholders (owners of family history programs and diagnostic facilities, such as Myriad Genetics) to make their programs interoperable with the HL7 specification.
As an example, we show here fragments of a Family History sample XML that represents clinical and genomics data of a patient who has a mother and a father (each has two parents), two sisters, a husband, and a daughter. The full sample is presented in Appendix B, and it is recommended that you copy it into a separate file and open that file with a browser for best viewing of the structure as well as the content of the sample.
The XML instance starts with the Patient as the root element (see Table 4 ).
Note that the patient as well as each of her relatives has optional nested ID elements that identify their ID and role; for example, NMTH is an HL7 code that means natural mother.
The fragment in Table 5 describes the daughter of the patient who died of breast cancer. The genomic data appear first, identifying a specific allele of the BRCA2 gene.
The fragment in Table 6 shows an elaboration of that BRCA2 allele by encapsulating sequences from that allele that might consist of personal SNPs beyond those variations that identified this allele. Note that the DNA sequences below are presented for illustration purposes only and are not necessarily accurate.
Finally, the fragment in Table 7 shows a few of the SNPs from the BRCA2 allele, represented with BSML within the encapsulated object (using the Isoform element). In contrast, the element derivedSequenceVariation represents an object of the Genotype model that holds the results of the bubbling-up processing, picking on a specific SNP and representing it as a deleterious mutation. The mutation is then associated with clinical phenotypes (clinical observation from the patient medical records).
Note that only the observation id appears in this XML instance, because it is represented by the ISO OID (Object Identifier) standard, which ensures uniqueness of object identifiers across systems and organizations and thus enables services to resolve the location of an object such as this patient's diagnosis and to get it from where it is being stored.
The value element is the end of the encapsulation portion, because the raw genomic data are encapsulated in the value attribute of the HL7 Sequence object. The reference tag allows referencing back to the BSML Isoform element. This referencing enables the association between the bubbled-up object like the 185delAG mutation to the encapsulated data as evidence. On the other hand, the mutation object is associated with clinical information to enable its usability within EHR systems. xsi:schemaLocation="urn:hl7-org:v3POCG_MT004008.xsd"> <id extension="555.001-SUBJ"/> <id extension="555.002-NMTH"/> <id extension="555.003-NFTH"/> <!--PATIENT--> <patientPerson> <administrativeGenderCode code="F"/> <birthTime value="1957"/> … Table 5 . Family history XML sample: The daughter fragment <!--DAUGHTER--> <relationshipHolder> <id extension="555.011-SUBJ"/> <id extension="555.001-NMTH"/> <id extension="555.01-NFTH"/> <code code="DAU"/> <relationshipHolder> <deceasedInd value="true"/> </relationshipHolder> <!--GENOMIC DATA--> <subjectOf> <Genotype> <component2> <individualAllele> <text>breast cancer 2, early onset</text> <value code="U43746" displayName="BRCA2" codeSystemName ="HUGO"/> … Table 6 . Family history XML sample: The sequencing fragment <sequence> <code code="BSMLcon3"/> <value> <Definitions> <Sequences> <Sequence id="seq1" molecule="dna" ic-acckey="U14680 REGION: 101..199" db-source="GenBank" title="BRCA1, exon 2" representation="raw" local-acckey="this could be used by the genetic lab"> <Seq-data> GCTCCCA CTCCATGAGG TATTTCTTCA CATCCGTGTC CCGGCCCGGC CGCGGGGAGC CCCGCTTCAT CGCCGTGGGC TACGTGGACG ACACGCAGTT CGTGCGGTTC GACAGCGACG CCGCGAGCCA GAGGATGGAG CCGCGGGCGC CGTGGATAGA GCAGGAGGGG CCGGAGTATT GGGACCAGGA GACACGGAAT GTGAAGGCCC AGTCACAGAC TGACCGAGTG GACCTGGGGA CCCTGCGCGG CTACTACAAC CAGAGCGAGG CCG </Seq-data> </Sequence> …
CONCLUSION
The vision of the semantic Web could play a major role in the current efforts to achieve interoperability of disparate health information systems. In this article, we have focused on the use case of exchanging family history data, which is crucial for breast cancer patients. In particular, elaborated family history with raw genomic data is becoming more important as clinicalgenomics correlations are now a standard part of modern health care.
While we have focused on breast cancer family history, this model has the generalizability to be utilized to exchange family history information for any hereditary condition. Hereditary conditions (benign or malignant) tend to be defined by the number of relatives with a condition or conditions, the age at which those conditions occur, and the closeness of that relative to the patient (degree of relative). In addition, if genetic testing is undertaken, the genetic mutation is discovered. Our model collects this information in a uniform format.
For example, let us consider a family suspected of having hemochromatosis (Toland, 2000) , a benign condition that causes the cells of the body to retain more iron than they need, which can lead to diabetes, heart disease, liver disease, and ar- Table 7 . Family history XML sample: The bubbling-up fragment <Isoforms> <Isoform-set> <Isoform id="SNP123" seqref="seq1" location="9" change="T"/> <Isoform id="SNP456" seqref="seq1" location="32" change="C"/> <Isoform id="SNP789" seqref="seq2" location="124" change="G"/> </Isoform-set> </Isoforms> </Definitions> </value> <methodCode code="SBT"/> <derivation4> <derivedSequenceVariation> <code code="DNA"/> <text> <reference value="#SNP456"/> </text> <!--MUTATION--> <value xsi:type="CE" code="185delAG"/> <interpretationCode code="DELETERIOUS"/> <pertinentInformation> <pertinentClinicalPhenotype> <reference typeCode="SUBJ"> <referredToExternalClinicalPhenotype> <id root="2.16.840.1.113883" extension="diagnosis1"/> </referredToExternalClinicalPhenotype> </reference> </pertinentClinicalPhenotype> </pertinentInformation> … thritis. The important information would be the presence of liver disease, diabetes, and so forth in various relatives, the age of onset of these conditions in each relative, the bloodline and the ability to show the relative in a pedigree, and whether genetic testing was done, which test was done, what the actual result was, and what the interpretation is. All these data items have placeholders in the HL7 model described in this article.
As a more abstract conception, in thinking about other indicators of hereditary conditions, we can conceive of a condition where the genetic test is not available or was not performed, but a laboratory test might give useful information. In our model, laboratory test results can be transmitted for each individual and can be displayed on a pedigree or run through a model. Some conditions may require the interaction of multiple genes, and our model allows the representation of multiple genetic test results for each relative.
Whatever condition is suspected or whatever data is collected, our model allows the transmission of this data from clinician to clinician as a message and, in addition, allows this information to be used to draw pedigrees and to run computer models of risk.
The importance of drawing a pedigree should not be underestimated. A pedigree is a graphical display of the family history information that allows the clinician to visualize the diseases and the relationships, and thus to be able to interpret the data better. In addition, the data are in a format that can be imported easily into computer models of risk in order to provide quantitative analyses of the likelihood of the condition for various family members.
Our HL7 model allows the transmission of all pertinent information for any hereditary condition of which we currently can conceive and has the flexibility to be extended to future, more complex genetic conditions.
We envision the use of services based on health standards over the Web that various family history specialized applications will be able to use to seamlessly exchange family history data. These services will be part of the entire set of health services being defined by major standardization bodies such as HL7 and OMG. In the development of the Family History model, we used the HL7 development methodology and the HL7 dedicated tooling. We thus defined the semantics of the payload of family history services, and as the aforementioned health services technical framework becomes available, our Family History model could be utilized by those services as the domain-specific ontology.
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